Determination of the α/β ratio for the normal liver on the basis of radiation-induced hepatic toxicities in patients with hepatocellular carcinoma
Open Access
- 15 March 2013
- journal article
- research article
- Published by Springer Nature in Radiation Oncology
- Vol. 8 (1) , 61
Abstract
The purpose of this study was to determine the α/β ratio for normal liver with hepatitis by analyzing the toxicity data from patients with unresectable hepatocellular carcinoma treated with helical tomotherapy. Between March 2006 and February 2012, 98 patients were eligible for this study. 66 patients received 45–50 Gy in 4.5-5 Gy fractions (Group A) and 32 patients received 36–60 Gy in 2.5-3 Gy fractions (Group B). Radiation-induced hepatic toxicity was defined as an increase of at least 2 points in the Child-Pugh score within 4 months of completing helical tomotherapy. We attempted to find the statistically significant parameters in the 2 groups using α/β ratios of 2, 4, 6, 8, or 10, and compared the estimated probability curves of each significant parameter. We hypothesized that the α/β ratio associated with the best matches for the curves between the 2 groups would be equivalent to the α/β ratio for the normal liver. When using an α/β ratio of 2 or 4, different parameters were found to be statistically significant in a multivariate analysis (Group A: VBED30 for α/β ratio = 2 and VBED25 for α/β ratio = 4, Group B: VBED25 for α/β ratio = 2 and VBED20 for α/β ratio = 4). When using an α/β ratio of 6, 8, or 10, VBED20 was found to be a statistically significant parameter in both groups. Comparison of the estimated probability curve of each significant parameter between the groups revealed that an α/β ratio of 8 resulted in the best matches. We suggest that the α/β ratio of the normal liver with hepatitis is 8. We hope that previously reported parameters and their values can be effectively used in different fractionation schemes by calculating the biologically effective dose using an α/β ratio of 8.Keywords
This publication has 21 references indexed in Scilit:
- Dosimetric predictor identification for radiation-induced liver disease after hypofractionated conformal radiotherapy for primary liver carcinoma patients with Child–Pugh Grade A cirrhosisRadiotherapy and Oncology, 2011
- Stereotactic Body Radiotherapy for Patients With Unresectable Primary Hepatocellular Carcinoma: Dose-Volumetric Parameters Predicting the Hepatic ComplicationInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- Radiotherapeutic Parameters Predictive of Liver Complications Induced by Liver Tumor RadiotherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2009
- Dose–volumetric parameters predicting radiation-induced hepatic toxicity in unresectable hepatocellular carcinoma patients treated with three-dimensional conformal radiotherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2007
- Radiation-induced liver disease in three-dimensional conformal radiation therapy for primary liver carcinoma: The risk factors and hepatic radiation toleranceInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2006
- Use of principal component analysis to evaluate the partial organ tolerance of normal tissues to radiationInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2005
- Biologic susceptibility of hepatocellular carcinoma patients treated with radiotherapy to radiation-induced liver diseaseInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2004
- Radiation-induced liver disease after three-dimensional conformal radiotherapy for patients with hepatocellular carcinoma: dosimetric analysis and implicationInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2002
- Analysis of radiation-induced liver disease using the Lyman NTCP modelInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2002
- Natural history of hepatocellular carcinoma and prognosis in relation to treatment study of 850 patientsCancer, 1985